CUE icon

Cue Biopharma

97 hedge funds and large institutions have $241M invested in Cue Biopharma in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

2.37% less ownership

Funds ownership: 66.16%63.79% (-2.4%)

17% less capital invested

Capital invested by funds: $291M → $241M (-$49.8M)

87% less call options, than puts

Call options by funds: $359K | Put options by funds: $2.72M

Holders
97
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$359K
Puts
$2.72M
Net Calls
Net Calls Change

Top Buyers

1 +$5.98M
2 +$3.79M
3 +$2.46M
4
Millennium Management
Millennium Management
New York
+$2.28M
5
Goldman Sachs
Goldman Sachs
New York
+$2.2M

Top Sellers

1 -$17.7M
2 -$5.06M
3 -$2.37M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.12M
5
BL
Bleichroeder LP
New York
-$938K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.25M
27
$1.06M
28
$938K
29
$895K
30
$854K
31
$824K
32
$804K
33
$797K
34
$786K
35
$701K
36
$694K
37
$668K
38
$658K
39
$636K
40
$554K
41
$473K
42
$471K
43
$437K
44
$399K
45
$391K
46
$356K
47
$348K
48
$339K
49
$328K
50
$318K